OT: A choice between [Design Issues]

posted by BEQool  – 2024-10-23 13:02 (222 d 10:53 ago) – Posting: # 24246
Views: 5,490

Dear Helmut,

❝ The original post is five years old… At the time being 0.05 indeed. The 0.1 was used by the FDA in analogy of Grizzle’s dreadful test1 for unequal carryover.“

❝ [...]Make your pick.

Thanks for a thorough answer.
Regarding the choice of alpha level of 0.05 or 0.1 - every sponsor would probbaly choose 0.05 in order to decrease the chance of detecting an interaction?


Dear Mittyri,
good one :ok: (with alpha-value instead of p-value in the picture)
As written above, every sponsor would probably take the blue one :-D


Regards
BEQool

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,682 registered users;
25 visitors (0 registered, 25 guests [including 15 identified bots]).
Forum time: 23:56 CEST (Europe/Vienna)

EMEA. The European Medicines Evaluation Agency.
The drug regulatory agency of the European Union.
A statistician-free zone.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5